Predictive Oncology Q3 EPS loss $(107.24); records $74.4M derivative liability on ATH token strategy

Axe Compute Inc.

Revenue of $3,618 virtually unchanged from $3,907 in Q3 2024; cash fell to $181,667 from $611,822 at Dec 31, 2024.
GAAP net loss per share from continuing operations of $(107.24), including a $74.4M loss on derivative instruments.
Held 5.70 billion ATH tokens as of Nov 10, 2025; market value ~$152.8M, with 3.7B locked and 2.0B unlocked.
Received ~$50.8M cash proceeds and ~$292.7M in-kind ATH notional from two private placements under new digital asset treasury strategy.
Appointed Shawn Matthews (former CEO of Cantor Fitzgerald) to Board of Directors; strategic collaboration with Every Cure announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.